Literature DB >> 23596005

Bone marrow tinctures for cardiovascular disease: lost in translation.

Jalees Rehman.   

Abstract

Entities:  

Keywords:  Editorials; angiogenesis; coronary artery disease; mesenchymal stromal cells; myocardial infarction; stem cells; tissue therapy

Mesh：

Year:  2013        PMID： 23596005      PMCID： PMC3885327          DOI： 10.1161/CIRCULATIONAHA.113.002775

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  16 in total

1.  Mixed results for bone marrow–derived cell therapy for ischemic heart disease.

Authors:  Eduardo Marbán; Konstantinos Malliaras
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272

2.  Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.

Authors:  Daniel Sürder; Robert Manka; Viviana Lo Cicero; Tiziano Moccetti; Kaspar Rufibach; Sabrina Soncin; Lucia Turchetto; Marina Radrizzani; Giuseppe Astori; Juerg Schwitter; Paul Erne; Michel Zuber; Christoph Auf der Maur; Peiman Jamshidi; Oliver Gaemperli; Stephan Windecker; Aris Moschovitis; Andreas Wahl; Ines Bühler; Christophe Wyss; Sebastian Kozerke; Ulf Landmesser; Thomas F Lüscher; Roberto Corti
Journal:  Circulation       Date:  2013-04-17       Impact factor: 29.690

3.  Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.

Authors:  Ketil Lunde; Svein Solheim; Svend Aakhus; Harald Arnesen; Michael Abdelnoor; Torstein Egeland; Knut Endresen; Arnfinn Ilebekk; Arild Mangschau; Jan G Fjeld; Hans Jørgen Smith; Eli Taraldsrud; Haakon Kiil Grøgaard; Reidar Bjørnerheim; Magne Brekke; Carl Müller; Einar Hopp; Asgrimur Ragnarsson; Jan E Brinchmann; Kolbjørn Forfang
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

4.  Autologous transplantation of bone marrow cells improves damaged heart function.

Authors:  S Tomita; R K Li; R D Weisel; D A Mickle; E J Kim; T Sakai; Z Q Jia
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans.

Authors:  Bodo E Strauer; Michael Brehm; Tobias Zeus; Matthias Köstering; Anna Hernandez; Rüdiger V Sorg; Gesine Kögler; Peter Wernet
Journal:  Circulation       Date:  2002-10-08       Impact factor: 29.690

6.  One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction.

Authors:  M Penicka; O Lang; P Widimsky; P Kobylka; T Kozak; T Vanek; J Dvorak; J Tintera; J Bartunek
Journal:  Heart       Date:  2007-02-19       Impact factor: 5.994

7.  Bone marrow cells regenerate infarcted myocardium.

Authors:  D Orlic; J Kajstura; S Chimenti; I Jakoniuk; S M Anderson; B Li; J Pickel; R McKay; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Nature       Date:  2001-04-05       Impact factor: 49.962

8.  Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial.

Authors:  Gervasio A Lamas; Christine Goertz; Robin Boineau; Daniel B Mark; Theodore Rozema; Richard L Nahin; Lauren Lindblad; Eldrin F Lewis; Jeanne Drisko; Kerry L Lee
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

9.  Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.

Authors:  Jay H Traverse; Timothy D Henry; Carl J Pepine; James T Willerson; David X M Zhao; Stephen G Ellis; John R Forder; R David Anderson; Antonis K Hatzopoulos; Marc S Penn; Emerson C Perin; Jeffrey Chambers; Kenneth W Baran; Ganesh Raveendran; Charles Lambert; Amir Lerman; Daniel I Simon; Douglas E Vaughan; Dejian Lai; Adrian P Gee; Doris A Taylor; Christopher R Cogle; James D Thomas; Rachel E Olson; Sherry Bowman; Judy Francescon; Carrie Geither; Eileen Handberg; Casey Kappenman; Lynette Westbrook; Linda B Piller; Lara M Simpson; Sarah Baraniuk; Catalin Loghin; David Aguilar; Sara Richman; Claudia Zierold; Daniel B Spoon; Judy Bettencourt; Shelly L Sayre; Rachel W Vojvodic; Sonia I Skarlatos; David J Gordon; Ray F Ebert; Minjung Kwak; Lemuel A Moyé; Robert D Simari
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272

10.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962
View more
  5 in total

Review 1.  Bioenergetic shifts during transitions between stem cell states (2013 Grover Conference series).

Authors:  Lianghui Zhang; Glenn Marsboom; Danielle Glick; Yanmin Zhang; Peter T Toth; Nicole Jones; Asrar B Malik; Jalees Rehman
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

2.  Cardiac stem cells: translation to human studies.

Authors:  Zijun Ge; Sean Lal; Thi Y L Le; Cris Dos Remedios; James J H Chong
Journal:  Biophys Rev       Date:  2014-12-03

Review 3.  Preclinical Studies of Stem Cell Therapy for Heart Disease.

Authors:  Bryon A Tompkins; Wayne Balkan; Johannes Winkler; Mariann Gyöngyösi; Georg Goliasch; Francisco Fernández-Avilés; Joshua M Hare
Journal:  Circ Res       Date:  2018-03-30       Impact factor: 17.367

Review 4.  Cell therapy for cardiac repair--lessons from clinical trials.

Authors:  Atta Behfar; Ruben Crespo-Diaz; Andre Terzic; Bernard J Gersh
Journal:  Nat Rev Cardiol       Date:  2014-03-04       Impact factor: 32.419

Review 5.  Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons?

Authors:  Song-Yan Liao; Hung-Fat Tse
Journal:  Stem Cell Res Ther       Date:  2013-12-24       Impact factor: 6.832
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.